BriaCell Therapeutics Corp.
- Last sale
- Nov 12, 2026 · -2.52%
- Market cap
- $30.39M
- 8.73M shares
- Filings
- 324
—
—
—FY 2026N/M FY26 yoy
FY 2026N/M FY26 yoy
FY 2026derivedN/M FY26 yoy
FY 2026N/M FY26 yoy
FY 2026−6.1% FY26 yoy
- $30.39M
- —
- —
- 2.0×
- -94.70%
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Taxes Other Than Income Taxes
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-07-31 | $965,764 | reported | |
| FY 2025 | 2025-07-31 | $1,039,193 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $47.29K | $47.29K | — | 15.98M sh | +3.0% | — |
| FY2022 | — | $10.17M | $10.17M | — | 15.52M sh | +1.6% | — |
Pharmaceutical preparations
BriaCell Therapeutics Corp. is the 363rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SCYXScynexis Inc$20.6M449.9%41.8%$32.9MPMNProMIS Neurosciences Inc.———$31.6M
BCTXBriaCell Therapeutics Corp. (this company)———$30.4M
CLCSCell Source, Inc.Fiscal 2024 figures———$29.9MRMTIRockwell Medical, Inc.$69.3M31.8%7.7%$29.6MPVCTProvectus Biopharmaceuticals, Inc.$336.1K45.5%1,615.8%$29.2MBETRFBetterLife Pharma Inc.Fiscal 2018 figures———$28.9MNXTCNextCure, Inc.———$28.0MACETAdicet Bio, Inc.———$27.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
BriaCell Therapeutics Corp. · CIK 1610820 · Engraved from SEC EDGAR